| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Capsid Proteins | 11 | 2015 | 74 | 1.150 |
Why?
|
| Oncogene Proteins, Viral | 10 | 2015 | 25 | 1.120 |
Why?
|
| Papillomavirus Vaccines | 8 | 2015 | 168 | 0.920 |
Why?
|
| Acetyltransferases | 4 | 2004 | 27 | 0.870 |
Why?
|
| Papillomavirus Infections | 10 | 2015 | 363 | 0.810 |
Why?
|
| Histone Acetyltransferases | 6 | 2007 | 20 | 0.740 |
Why?
|
| Transcription Factors | 6 | 2018 | 722 | 0.670 |
Why?
|
| Papillomaviridae | 7 | 2012 | 136 | 0.650 |
Why?
|
| Cell Cycle Proteins | 3 | 2007 | 239 | 0.620 |
Why?
|
| Human papillomavirus 16 | 7 | 2013 | 37 | 0.530 |
Why?
|
| Spectrum Analysis, Raman | 2 | 2017 | 94 | 0.440 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2022 | 159 | 0.440 |
Why?
|
| Enzyme Inhibitors | 6 | 2010 | 457 | 0.440 |
Why?
|
| Histones | 4 | 2009 | 194 | 0.430 |
Why?
|
| Urinary Bladder Neoplasms | 3 | 2019 | 84 | 0.410 |
Why?
|
| Drug Discovery | 1 | 2014 | 106 | 0.400 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2014 | 183 | 0.390 |
Why?
|
| Prostatic Neoplasms | 4 | 2024 | 1068 | 0.380 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2015 | 293 | 0.380 |
Why?
|
| Adjuvants, Immunologic | 4 | 2015 | 117 | 0.350 |
Why?
|
| Ovarian Neoplasms | 3 | 2023 | 406 | 0.350 |
Why?
|
| Animals | 29 | 2023 | 16695 | 0.350 |
Why?
|
| Mice | 20 | 2023 | 6490 | 0.350 |
Why?
|
| Transcription, Genetic | 5 | 2019 | 599 | 0.340 |
Why?
|
| Hela Cells | 6 | 2014 | 370 | 0.340 |
Why?
|
| Chromatin | 4 | 2023 | 179 | 0.340 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2010 | 35 | 0.330 |
Why?
|
| Saponins | 2 | 2015 | 7 | 0.330 |
Why?
|
| Repressor Proteins | 4 | 2015 | 267 | 0.330 |
Why?
|
| Antibodies, Viral | 8 | 2015 | 295 | 0.330 |
Why?
|
| Protein-Arginine N-Methyltransferases | 1 | 2009 | 7 | 0.320 |
Why?
|
| Ellagic Acid | 1 | 2009 | 4 | 0.320 |
Why?
|
| Humans | 41 | 2024 | 42163 | 0.320 |
Why?
|
| Arginine | 1 | 2009 | 75 | 0.310 |
Why?
|
| Molecular Sequence Data | 7 | 2009 | 1559 | 0.300 |
Why?
|
| Uterine Cervical Neoplasms | 3 | 2010 | 350 | 0.300 |
Why?
|
| Amino Acid Sequence | 6 | 2009 | 1188 | 0.290 |
Why?
|
| Activating Transcription Factor 2 | 1 | 2007 | 3 | 0.270 |
Why?
|
| Neoplasm Proteins | 2 | 2019 | 228 | 0.260 |
Why?
|
| Trans-Activators | 2 | 2005 | 190 | 0.250 |
Why?
|
| Breast Neoplasms | 4 | 2022 | 1679 | 0.250 |
Why?
|
| Kinetics | 4 | 2014 | 698 | 0.250 |
Why?
|
| Female | 28 | 2023 | 24018 | 0.240 |
Why?
|
| Nuclear Proteins | 2 | 2005 | 330 | 0.240 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2019 | 933 | 0.240 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2023 | 201 | 0.230 |
Why?
|
| Acetylation | 4 | 2007 | 108 | 0.230 |
Why?
|
| Neutralization Tests | 6 | 2013 | 55 | 0.230 |
Why?
|
| Neoplasms | 4 | 2019 | 1341 | 0.220 |
Why?
|
| Cell Line, Tumor | 11 | 2021 | 2598 | 0.220 |
Why?
|
| Anacardic Acids | 2 | 2005 | 2 | 0.220 |
Why?
|
| Terpenes | 1 | 2004 | 29 | 0.210 |
Why?
|
| Carcinoma, Pancreatic Ductal | 2 | 2016 | 60 | 0.210 |
Why?
|
| Protein Structure, Tertiary | 4 | 2009 | 427 | 0.210 |
Why?
|
| Prostatic Hyperplasia | 1 | 2024 | 32 | 0.210 |
Why?
|
| Metabolome | 3 | 2019 | 50 | 0.200 |
Why?
|
| Gene Expression Regulation | 2 | 2009 | 1066 | 0.200 |
Why?
|
| Salicylates | 1 | 2003 | 9 | 0.200 |
Why?
|
| Virion | 3 | 2012 | 73 | 0.200 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2023 | 14 | 0.200 |
Why?
|
| Curcumin | 1 | 2004 | 115 | 0.200 |
Why?
|
| Multiple Myeloma | 1 | 2023 | 45 | 0.200 |
Why?
|
| Mice, Nude | 4 | 2021 | 403 | 0.190 |
Why?
|
| Antineoplastic Agents | 4 | 2021 | 979 | 0.190 |
Why?
|
| Mice, Inbred BALB C | 7 | 2015 | 686 | 0.190 |
Why?
|
| Receptors, Calcitriol | 1 | 2023 | 69 | 0.190 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2023 | 97 | 0.190 |
Why?
|
| Pancreatic Neoplasms | 2 | 2016 | 206 | 0.180 |
Why?
|
| Quinolines | 1 | 2022 | 76 | 0.180 |
Why?
|
| p300-CBP Transcription Factors | 3 | 2007 | 14 | 0.180 |
Why?
|
| Benzylidene Compounds | 1 | 2021 | 5 | 0.180 |
Why?
|
| Membrane Glycoproteins | 2 | 2013 | 221 | 0.170 |
Why?
|
| Models, Molecular | 4 | 2010 | 875 | 0.170 |
Why?
|
| Mannose-Binding Lectins | 1 | 2020 | 14 | 0.160 |
Why?
|
| Rabbits | 5 | 2013 | 292 | 0.160 |
Why?
|
| Viral Vaccines | 2 | 2012 | 36 | 0.160 |
Why?
|
| Molecular Structure | 3 | 2009 | 560 | 0.160 |
Why?
|
| Aldehyde Oxidase | 1 | 2019 | 1 | 0.160 |
Why?
|
| Uridine Diphosphate Glucose Dehydrogenase | 1 | 2019 | 2 | 0.160 |
Why?
|
| Cisplatin | 2 | 2023 | 91 | 0.160 |
Why?
|
| Urinary Bladder | 1 | 2019 | 30 | 0.160 |
Why?
|
| Cell Line | 4 | 2011 | 1416 | 0.150 |
Why?
|
| Hyaluronic Acid | 1 | 2019 | 36 | 0.150 |
Why?
|
| Disease Progression | 3 | 2019 | 661 | 0.150 |
Why?
|
| Carnitine O-Palmitoyltransferase | 1 | 2019 | 10 | 0.150 |
Why?
|
| Databases, Nucleic Acid | 1 | 2019 | 30 | 0.150 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2014 | 1112 | 0.150 |
Why?
|
| Antibodies, Neutralizing | 4 | 2015 | 118 | 0.150 |
Why?
|
| Cell Proliferation | 6 | 2021 | 1420 | 0.140 |
Why?
|
| Fatty Acids | 1 | 2019 | 134 | 0.140 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2017 | 16 | 0.140 |
Why?
|
| Femur Head Necrosis | 1 | 2017 | 1 | 0.140 |
Why?
|
| Receptors, Estrogen | 1 | 2019 | 177 | 0.140 |
Why?
|
| Apoptosis | 6 | 2021 | 1541 | 0.140 |
Why?
|
| Epitopes | 4 | 2013 | 155 | 0.130 |
Why?
|
| Receptors, Androgen | 1 | 2018 | 144 | 0.130 |
Why?
|
| DNA Methylation | 2 | 2018 | 393 | 0.130 |
Why?
|
| Antibodies, Monoclonal | 2 | 2009 | 301 | 0.130 |
Why?
|
| Mutagens | 1 | 2017 | 76 | 0.130 |
Why?
|
| Carcinogens | 1 | 2017 | 126 | 0.130 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2017 | 150 | 0.130 |
Why?
|
| Papillomavirus E7 Proteins | 3 | 2015 | 16 | 0.120 |
Why?
|
| Mitochondria | 1 | 2019 | 516 | 0.110 |
Why?
|
| DNA Damage | 1 | 2017 | 358 | 0.110 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2009 | 233 | 0.110 |
Why?
|
| Neoplasm Metastasis | 4 | 2018 | 233 | 0.110 |
Why?
|
| Vagina | 2 | 2013 | 89 | 0.110 |
Why?
|
| Felodipine | 1 | 2014 | 1 | 0.110 |
Why?
|
| Male | 11 | 2024 | 22779 | 0.110 |
Why?
|
| Protein Transport | 2 | 2014 | 295 | 0.110 |
Why?
|
| CD8-Positive T-Lymphocytes | 3 | 2015 | 181 | 0.110 |
Why?
|
| Binding, Competitive | 1 | 2014 | 107 | 0.110 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2014 | 31 | 0.110 |
Why?
|
| Transcriptional Activation | 2 | 2005 | 173 | 0.110 |
Why?
|
| Piperidones | 1 | 2013 | 9 | 0.110 |
Why?
|
| Surface Properties | 1 | 2014 | 157 | 0.100 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2004 | 198 | 0.100 |
Why?
|
| Metabolomics | 3 | 2019 | 90 | 0.100 |
Why?
|
| Cell Death | 1 | 2014 | 277 | 0.100 |
Why?
|
| Nogalamycin | 1 | 2013 | 1 | 0.100 |
Why?
|
| Digitoxin | 1 | 2013 | 7 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 5 | 2021 | 1804 | 0.100 |
Why?
|
| Cell Cycle | 1 | 2014 | 348 | 0.100 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2009 | 189 | 0.100 |
Why?
|
| Cytokines | 2 | 2023 | 661 | 0.090 |
Why?
|
| MicroRNAs | 1 | 2018 | 501 | 0.090 |
Why?
|
| Cell Nucleus | 1 | 2014 | 383 | 0.090 |
Why?
|
| Vaccination | 2 | 2015 | 332 | 0.090 |
Why?
|
| Capsid | 1 | 2011 | 64 | 0.090 |
Why?
|
| Cross Reactions | 2 | 2008 | 86 | 0.090 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2011 | 115 | 0.090 |
Why?
|
| Chalcones | 1 | 2010 | 15 | 0.090 |
Why?
|
| Cottontail rabbit papillomavirus | 1 | 2010 | 1 | 0.080 |
Why?
|
| Peptides | 3 | 2013 | 357 | 0.080 |
Why?
|
| Human papillomavirus 18 | 1 | 2010 | 6 | 0.080 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 1058 | 0.080 |
Why?
|
| Presenilin-1 | 1 | 2010 | 27 | 0.080 |
Why?
|
| Genitalia, Female | 1 | 2010 | 29 | 0.080 |
Why?
|
| Smoking | 1 | 2017 | 1019 | 0.080 |
Why?
|
| Quinazolines | 2 | 2022 | 37 | 0.080 |
Why?
|
| Plant Extracts | 2 | 2004 | 303 | 0.080 |
Why?
|
| Lythraceae | 1 | 2009 | 3 | 0.080 |
Why?
|
| Xenopus laevis | 1 | 2009 | 72 | 0.080 |
Why?
|
| Proline | 1 | 2009 | 39 | 0.080 |
Why?
|
| Methylation | 1 | 2009 | 118 | 0.080 |
Why?
|
| Tissue Array Analysis | 2 | 2019 | 79 | 0.080 |
Why?
|
| Injections, Subcutaneous | 1 | 2008 | 35 | 0.080 |
Why?
|
| Cells, Cultured | 2 | 2010 | 1617 | 0.070 |
Why?
|
| Macaca | 1 | 2008 | 36 | 0.070 |
Why?
|
| Immunization, Secondary | 1 | 2008 | 15 | 0.070 |
Why?
|
| Thermodynamics | 1 | 2009 | 226 | 0.070 |
Why?
|
| Gene Knockdown Techniques | 2 | 2019 | 188 | 0.070 |
Why?
|
| Host-Pathogen Interactions | 1 | 2010 | 203 | 0.070 |
Why?
|
| B-Lymphocytes | 1 | 2009 | 183 | 0.070 |
Why?
|
| Ubiquitination | 2 | 2021 | 60 | 0.070 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2019 | 339 | 0.070 |
Why?
|
| Tumor Virus Infections | 1 | 2007 | 22 | 0.070 |
Why?
|
| Vaccines, DNA | 1 | 2007 | 24 | 0.070 |
Why?
|
| Arylalkylamine N-Acetyltransferase | 1 | 2007 | 5 | 0.070 |
Why?
|
| Leucine Zippers | 1 | 2007 | 5 | 0.070 |
Why?
|
| COS Cells | 1 | 2007 | 67 | 0.070 |
Why?
|
| Mice, Knockout | 1 | 2010 | 1010 | 0.070 |
Why?
|
| Biotinylation | 1 | 2006 | 12 | 0.070 |
Why?
|
| Neoplasm Staging | 2 | 2019 | 366 | 0.060 |
Why?
|
| Fourier Analysis | 1 | 2006 | 45 | 0.060 |
Why?
|
| Circular Dichroism | 1 | 2006 | 64 | 0.060 |
Why?
|
| DNA, Viral | 2 | 2007 | 323 | 0.060 |
Why?
|
| Sequence Deletion | 1 | 2006 | 92 | 0.060 |
Why?
|
| Quantitative Structure-Activity Relationship | 1 | 2007 | 110 | 0.060 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2006 | 140 | 0.060 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2012 | 456 | 0.060 |
Why?
|
| Phenylephrine | 1 | 2005 | 32 | 0.060 |
Why?
|
| Corticotropin-Releasing Hormone | 1 | 2005 | 48 | 0.060 |
Why?
|
| Gene Products, tat | 1 | 2004 | 36 | 0.060 |
Why?
|
| Cadherins | 2 | 2016 | 102 | 0.060 |
Why?
|
| Garcinia | 1 | 2004 | 5 | 0.050 |
Why?
|
| Immunoprecipitation | 1 | 2004 | 128 | 0.050 |
Why?
|
| Axonemal Dyneins | 1 | 2024 | 6 | 0.050 |
Why?
|
| Transcriptional Elongation Factors | 1 | 2024 | 7 | 0.050 |
Why?
|
| Forecasting | 1 | 2004 | 136 | 0.050 |
Why?
|
| Anacardium | 1 | 2003 | 2 | 0.050 |
Why?
|
| Bleomycin | 1 | 2023 | 21 | 0.050 |
Why?
|
| Templates, Genetic | 1 | 2003 | 24 | 0.050 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2004 | 184 | 0.050 |
Why?
|
| Temperature | 1 | 2004 | 314 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2004 | 310 | 0.050 |
Why?
|
| Biology | 1 | 2022 | 20 | 0.050 |
Why?
|
| Seeds | 1 | 2003 | 46 | 0.050 |
Why?
|
| Myocytes, Cardiac | 1 | 2005 | 173 | 0.050 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2023 | 61 | 0.050 |
Why?
|
| Fruit | 1 | 2004 | 178 | 0.050 |
Why?
|
| Prostate | 1 | 2024 | 152 | 0.050 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2023 | 115 | 0.050 |
Why?
|
| Benzamides | 1 | 2003 | 78 | 0.050 |
Why?
|
| Blotting, Western | 1 | 2004 | 884 | 0.050 |
Why?
|
| Bacterial Proteins | 1 | 2006 | 580 | 0.050 |
Why?
|
| Recombinant Proteins | 1 | 2003 | 522 | 0.040 |
Why?
|
| Receptor, erbB-2 | 1 | 2022 | 149 | 0.040 |
Why?
|
| DNA Repair | 1 | 2022 | 196 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2023 | 379 | 0.040 |
Why?
|
| Amino Acid Substitution | 2 | 2011 | 135 | 0.040 |
Why?
|
| Lectins, C-Type | 1 | 2020 | 37 | 0.040 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2022 | 290 | 0.040 |
Why?
|
| Pentose Phosphate Pathway | 1 | 2019 | 2 | 0.040 |
Why?
|
| Kynurenine | 1 | 2019 | 8 | 0.040 |
Why?
|
| Uridine Diphosphate Glucuronic Acid | 1 | 2019 | 1 | 0.040 |
Why?
|
| NADP | 1 | 2019 | 37 | 0.040 |
Why?
|
| Chorioallantoic Membrane | 1 | 2019 | 11 | 0.040 |
Why?
|
| Nucleotides | 1 | 2019 | 37 | 0.040 |
Why?
|
| Chick Embryo | 1 | 2019 | 77 | 0.040 |
Why?
|
| Receptors, Cell Surface | 1 | 2020 | 146 | 0.040 |
Why?
|
| PPAR gamma | 1 | 2019 | 55 | 0.040 |
Why?
|
| Tryptophan | 1 | 2019 | 66 | 0.040 |
Why?
|
| Quality of Life | 1 | 2024 | 599 | 0.040 |
Why?
|
| Immunity, Innate | 1 | 2020 | 168 | 0.040 |
Why?
|
| Extracellular Matrix | 1 | 2019 | 129 | 0.040 |
Why?
|
| Alabama | 1 | 2018 | 52 | 0.040 |
Why?
|
| Neoplasm Invasiveness | 1 | 2019 | 284 | 0.040 |
Why?
|
| Epidermal Growth Factor | 1 | 2018 | 69 | 0.040 |
Why?
|
| Neoplasm Transplantation | 1 | 2018 | 129 | 0.040 |
Why?
|
| Breast | 1 | 2019 | 139 | 0.040 |
Why?
|
| Survival Rate | 1 | 2019 | 353 | 0.040 |
Why?
|
| Femur Head | 1 | 2017 | 3 | 0.030 |
Why?
|
| Nitrosamines | 1 | 2017 | 11 | 0.030 |
Why?
|
| Butanones | 1 | 2017 | 5 | 0.030 |
Why?
|
| Azacitidine | 1 | 2017 | 22 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2019 | 438 | 0.030 |
Why?
|
| Histocytochemistry | 1 | 2017 | 47 | 0.030 |
Why?
|
| Bone Remodeling | 1 | 2017 | 23 | 0.030 |
Why?
|
| Biophysical Phenomena | 1 | 2017 | 22 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2017 | 116 | 0.030 |
Why?
|
| Signal Transduction | 3 | 2015 | 2111 | 0.030 |
Why?
|
| Radiography | 1 | 2017 | 72 | 0.030 |
Why?
|
| DNA Adducts | 1 | 2017 | 41 | 0.030 |
Why?
|
| Mutation | 1 | 2022 | 1169 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2018 | 154 | 0.030 |
Why?
|
| Middle Aged | 3 | 2018 | 11819 | 0.030 |
Why?
|
| Microscopy, Electron | 1 | 2017 | 209 | 0.030 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2017 | 71 | 0.030 |
Why?
|
| Biopsy | 1 | 2017 | 176 | 0.030 |
Why?
|
| Bone Density | 1 | 2017 | 102 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2019 | 274 | 0.030 |
Why?
|
| Benzo(a)pyrene | 1 | 2017 | 128 | 0.030 |
Why?
|
| Liver Neoplasms | 1 | 2019 | 211 | 0.030 |
Why?
|
| Lymphatic Metastasis | 1 | 2016 | 81 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2016 | 84 | 0.030 |
Why?
|
| Adult | 3 | 2018 | 13458 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2016 | 122 | 0.030 |
Why?
|
| Databases, Genetic | 1 | 2016 | 103 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2017 | 928 | 0.030 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2015 | 64 | 0.030 |
Why?
|
| Oxidative Phosphorylation | 1 | 2015 | 56 | 0.030 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2015 | 89 | 0.030 |
Why?
|
| Glycolysis | 1 | 2015 | 71 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2015 | 174 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2017 | 845 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2017 | 577 | 0.030 |
Why?
|
| Adenosine Triphosphate | 1 | 2015 | 205 | 0.030 |
Why?
|
| Genes, p53 | 1 | 2013 | 28 | 0.030 |
Why?
|
| Pyrazines | 1 | 2013 | 24 | 0.030 |
Why?
|
| Boronic Acids | 1 | 2013 | 20 | 0.030 |
Why?
|
| Hypoxanthine Phosphoribosyltransferase | 1 | 2013 | 12 | 0.030 |
Why?
|
| Interleukin Receptor Common gamma Subunit | 1 | 2013 | 8 | 0.020 |
Why?
|
| Early Detection of Cancer | 1 | 2017 | 428 | 0.020 |
Why?
|
| Stromal Cells | 1 | 2013 | 54 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2017 | 1729 | 0.020 |
Why?
|
| Cardiotonic Agents | 1 | 2013 | 39 | 0.020 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2013 | 52 | 0.020 |
Why?
|
| Sex Factors | 1 | 2016 | 1008 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2013 | 158 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2013 | 506 | 0.020 |
Why?
|
| Luciferases | 1 | 2011 | 70 | 0.020 |
Why?
|
| Immunization | 1 | 2011 | 93 | 0.020 |
Why?
|
| Phenotype | 1 | 2014 | 774 | 0.020 |
Why?
|
| Cell Transformation, Viral | 1 | 2010 | 22 | 0.020 |
Why?
|
| Gene Expression | 1 | 2014 | 692 | 0.020 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2010 | 147 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2015 | 1586 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2010 | 189 | 0.020 |
Why?
|
| Bovine papillomavirus 1 | 1 | 2009 | 4 | 0.020 |
Why?
|
| Immune Sera | 1 | 2009 | 56 | 0.020 |
Why?
|
| Cysteine | 1 | 2009 | 101 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2010 | 491 | 0.020 |
Why?
|
| Virulence | 1 | 2009 | 238 | 0.020 |
Why?
|
| Rats | 2 | 2007 | 3701 | 0.020 |
Why?
|
| Antibody Formation | 1 | 2008 | 75 | 0.020 |
Why?
|
| Antigens, Viral | 1 | 2008 | 50 | 0.020 |
Why?
|
| Biolistics | 1 | 2007 | 1 | 0.020 |
Why?
|
| Calreticulin | 1 | 2007 | 8 | 0.020 |
Why?
|
| Rhodanine | 1 | 2007 | 3 | 0.020 |
Why?
|
| Acetyl Coenzyme A | 1 | 2007 | 8 | 0.020 |
Why?
|
| Tryptamines | 1 | 2007 | 7 | 0.020 |
Why?
|
| Immunization, Passive | 1 | 2007 | 19 | 0.020 |
Why?
|
| Lipoproteins | 1 | 2008 | 68 | 0.020 |
Why?
|
| Papilloma | 1 | 2007 | 17 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2009 | 574 | 0.020 |
Why?
|
| Pineal Gland | 1 | 2007 | 31 | 0.020 |
Why?
|
| Cricetinae | 1 | 2007 | 241 | 0.020 |
Why?
|
| Cell Survival | 1 | 2010 | 934 | 0.020 |
Why?
|
| Crystallography, X-Ray | 1 | 2007 | 285 | 0.020 |
Why?
|
| Melatonin | 1 | 2007 | 83 | 0.020 |
Why?
|
| Young Adult | 1 | 2017 | 4936 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2007 | 420 | 0.020 |
Why?
|
| Skin | 1 | 2007 | 185 | 0.020 |
Why?
|
| Drug Design | 1 | 2007 | 183 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2008 | 301 | 0.020 |
Why?
|
| Binding Sites | 1 | 2007 | 670 | 0.010 |
Why?
|
| United States | 1 | 2016 | 5072 | 0.010 |
Why?
|
| Urocortins | 1 | 2005 | 4 | 0.010 |
Why?
|
| E1A-Associated p300 Protein | 1 | 2005 | 11 | 0.010 |
Why?
|
| Cell Size | 1 | 2005 | 46 | 0.010 |
Why?
|
| Genotype | 1 | 2007 | 796 | 0.010 |
Why?
|
| Time Factors | 1 | 2009 | 1848 | 0.010 |
Why?
|
| Protein Binding | 1 | 2007 | 1076 | 0.010 |
Why?
|
| Base Sequence | 1 | 2005 | 997 | 0.010 |
Why?
|
| Aged | 1 | 2014 | 7982 | 0.010 |
Why?
|
| Pregnancy | 1 | 2005 | 1737 | 0.010 |
Why?
|